Home > Insider Trading > Filing (0000899243-18-030087)

Filing Details

Accession Number:: 0000899243-18-030087
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-04 19:01:41
Reporting Period:: 2018-12-03

Accepted Time:: 2018-12-04 19:01:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1707502	Solid Biosciences Inc.	SLDB	Biological Products, (No Disgnostic Substances) (2836)	900943402

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1727401	Armando Jorge Quiroz	C/O Solid Biosciences Inc. 141 Portland Street, 5Th Floor Cambridge MA 02139	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2018-12-03	1,200	$29.94	267,042	No	4	S	Direct
Common Stock	Disposition	2018-12-03	6,154	$30.21	260,888	No	4	S	Direct
Common Stock	Disposition	2018-12-03	31,426	$31.41	229,462	No	4	S	Direct
Common Stock	Disposition	2018-12-03	1,370	$32.24	228,092	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.90 to $29.99, inclusive. The reporting person undertakes to provide to the issuer, anysecurity holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.97, inclusive. The reporting person undertakes to provide to the issuer, anysecurity holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.01 to $31.98, inclusive. The reporting person undertakes to provide to the issuer, anysecurity holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.56, inclusive. The reporting person undertakes to provide to the issuer, anysecurity holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form.